Literature DB >> 30532892

Very late stent thrombosis at 2.5 years after sirolimus-eluting stent implantation with prior angioscopic image of culprit lesion: A case report.

Koshi Matsuo1, Yasunori Ueda1, Mayu Nishio1, Akio Hirata1, Mitsutoshi Asai1, Takayoshi Nemoto1, Kazunori Kashiwase1, Kazuhisa Kodama1.   

Abstract

Although very late stent thrombosis after drug-eluting stent implantation is a critical event, its cause has not been clarified. This is the first report of a case with very late stent thrombosis after drug-eluting stent implantation for which prior angioscopic image of the culprit lesion is available. A 54-year-old Japanese male patient with stable angina who received implantation of sirolimus-eluting stent at the culprit lesion and 1-year follow-up angiographic and angioscopic examinations came back with chest pain at rest at 2.5 years after the stent implantation. Very late stent thrombosis was diagnosed by emergent angiographic and angioscopic examinations and was treated by zotarolimus-eluting stent. One-year angiographic and angioscopic follow-up examinations after zotarolimus-eluting stent were performed. Angioscopy revealed uncovered stent strut, yellow plaques, and thrombus at 1-year follow-up after sirolimus-eluting stent implantation, and it confirmed the thrombotic occlusion inside the sirolimus-eluting stent at the time of emergent catheterization. This is a case of very late stent thrombosis in the drug-eluting stent where uncovered stent strut, yellow plaques, and thrombus had been detected by angioscopy 1.5 years before the onset. Those thrombogenic sources might be the cause of stent thrombosis.

Entities:  

Keywords:  Angioscopy; Neointima; Thrombus; Very late stent thrombosis; Yellow plaque

Year:  2011        PMID: 30532892      PMCID: PMC6265379          DOI: 10.1016/j.jccase.2011.10.009

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  5 in total

1.  Number of yellow plaques detected in a coronary artery is associated with future risk of acute coronary syndrome: detection of vulnerable patients by angioscopy.

Authors:  Tomohito Ohtani; Yasunori Ueda; Isamu Mizote; Jota Oyabu; Katsuki Okada; Atsushi Hirayama; Kazuhisa Kodama
Journal:  J Am Coll Cardiol       Date:  2006-05-15       Impact factor: 24.094

2.  Angioscopic comparison of neointimal coverage between zotarolimus- and sirolimus-eluting stents.

Authors:  Masaki Awata; Shinsuke Nanto; Masaaki Uematsu; Takakazu Morozumi; Tetsuya Watanabe; Toshinari Onishi; Osamu Iida; Fusako Sera; Jun-ichi Kotani; Masatsugu Hori; Seiki Nagata
Journal:  J Am Coll Cardiol       Date:  2008-08-26       Impact factor: 24.094

3.  Risk of in-stent thrombus formation at one year after drug-eluting stent implantation.

Authors:  Tomoaki Higo; Yasunori Ueda; Koshi Matsuo; Mayu Nishio; Akio Hirata; Mitsutoshi Asai; Takayoshi Nemoto; Ayaka Murakami; Kazunori Kashiwase; Kazuhisa Kodama
Journal:  Thromb Res       Date:  2011-06-14       Impact factor: 3.944

4.  Angioscopic evaluation of neointima coverage: sirolimus drug-eluting stent versus bare metal stent.

Authors:  Jota Oyabu; Yasunori Ueda; Nobuyuki Ogasawara; Katsuki Okada; Atsushi Hirayama; Kazuhisa Kodama
Journal:  Am Heart J       Date:  2006-12       Impact factor: 4.749

5.  Assessment of plaque vulnerability by angioscopic classification of plaque color.

Authors:  Yasunori Ueda; Tomohito Ohtani; Masahiko Shimizu; Atsushi Hirayama; Kazuhisa Kodama
Journal:  Am Heart J       Date:  2004-08       Impact factor: 4.749

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.